Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Poly Implant Prothèses (PIP) was a French medical device company founded in 1991 that specialized in the manufacture of silicone gel breast implants. At its peak, the company was one of the world's largest producers of breast implants, exporting products to over 60 countries for both cosmetic and reconstructive purposes. The company became the center of a global health scandal in 2010 when French authorities discovered that PIP had been using unapproved, industrial-grade silicone instead of medical-grade silicone in its products. This led to significantly higher rupture rates and inflammatory complications for hundreds of thousands of women worldwide. The company was liquidated in 2010, and its founder, Jean-Claude Mas, was later convicted of fraud.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Poly Implant Prothèses.